Why is this test performed?
- Accurate diagnosis of myeloid malignancies.
- Prognostic risk stratification of the disease.
- Guiding the selection of targeted or immunotherapy.
- Monitoring treatment response and minimal residual disease.
Book Myeloid Malignancy NGS Panel | Lahalak Medical Platform
Identify genetic mutations in myeloid malignancies using advanced NGS technology. This panel aids in precise risk stratification and helps clinicians design personalized treatment plans for AML, MDS, and MPN conditions.
Scientific name: Myeloid Malignancy NGS Panel
A sophisticated laboratory test utilizing Next-Generation Sequencing to detect gene mutations associated with AML, MDS, and MPN, facilitating accurate diagnosis and personalized prognostic risk assessment for patients.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Venous blood sample collection
- Next-Generation Sequencing analysis
- Detailed genetic results report
Medical Service Information
Conditions Covered
- Acute Myeloid Leukemia (AML).
- Myelodysplastic Syndromes (MDS).
- Myeloproliferative Neoplasms (MPN).
- Unexplained bone marrow failure cases.
Advantages of NGS Technology
- Simultaneous testing of multiple genes.
- High sensitivity for detecting rare mutations.
- Faster and more comprehensive than traditional genetic methods.
Conditions & Notices
- Preferable to provide previous medical reports if available
- No specific dietary preparations required
Medical services you might also like
